3D Cell Cultures: Technologies and Global Markets

Report Code: BIO140D

Publish Date: Mar 2024

Publisher: BCC Publishing

Category: Cell Biology

Download Report Overview

Single User License: $5500

Member Price: FREE

EXPLORE OFFERS

Use code SUMMER at checkout for 50% OFF

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.

Report Includes

  • 17 data tables and 105 additional tables
  • An overview of the global market landscape related to the 3D cell cultures technologies
  • In-depth analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
  • Evaluation of the current market size and revenue growth prospects specific to 3D cell cultures technologies, accompanied by a comprehensive market share analysis categorized by type, end user, and geographical region
  • Information on analytical systems used in tissue and cell culture, cellomics, and human cancer model initiative (HCMI)
  • Details about assay development for mesenchymal stem cells, In Vitro testing of adventitious agents and description of assays and assay kits
  • A look at the main classes of models for researching cancer and other diseases, benefits of 3D models to cancer research and description of 3D engineered scaffolds
  • Analysis of the market's dynamics, specifically growth drivers, restraints, and opportunities and discussion on the impact of COVID-19 on the world of cell culture
  • Insights into U.S. regulatory status of bioprinted products; basic guidance for the regulation of biologics, regenerative medicine and xenotransplants
  • Relevant patent analysis, including recent activity and a list of key patents
  • Detailed profiles of leading market participants, providing a descriptive overview of their respective businesses, including Abcam PLC, Agilent Technologies Inc., Corning Inc., Merck KGAA, Beckman Coulter, and Synvivo Inc.

Report Scope

This report aims to provide a comprehensive study of the global 3D cell culture technologies market. It provides a detailed description of the different types of healthcare interoperability solutions and their current and historical market revenues.

The scope of the report encompasses the major types of 3D cell culture which are being used by industry, academic researchers, government labs, and independent research groups. This includes the main inputs such as cell lines, media, sera, reagents, software, and instrumentation. It analyzes the current market status, examines future market drivers and presents forecasts of growth over the next five years.

The market structure has been reorganized for this edition. Also, more research was done on base case data for different product areas. The greater emphasis is on the different products used for 3D cell culture, but the report also investigates the market in terms of types of applications, end users and geographic regions.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size $2.5 billion
Market size forecast $14.8 billion
Growth rate CAGR of 26.5% for the forecast period of 2023-2028
Units considered $ Millions
Segments covered Type, Application, End-User, and Geographic Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World
Countries covered U.S, Canada, Mexico, France, Germany, Italy, Spain, UK, Russia, China, India, Japan, South Korea, and South Africa
Key Market Drivers
  • Government regulations and mandates.
  • Rising demand for tissue engineering.
  • Advancements in healthcare technology.
Companies studied
ZENBIO INC.TECAN TRADING AG
THERMO FISHER SCIENTIFIC INC.SYNVIVO INC.
ORGANOVO HOLDINGS INC.PLASTICELL
PROMEGA CORP.SARTORIUS AG
STEMCELL TECHNOLOGIESMIMETAS B.V.
LIFENET HEALTHMERCK KGAA
INVITROCUEKIYATEC
GREINER BIO-ONE INTERNATIONAL GMBHINSPHERO
EMULATE ENVISIONTEC US LLC
EPITHELIX EUROFINS SCIENTIFIC
DANAHER CORP.CYTOO SA
BICOCELL APPLICATIONS INC.
CORNING INC.ALPCO
AMS BIOTECHNOLOGY (EUROPE) LTD.AGILENT TECHNOLOGIES INC.
3D BIOPRINTING SOLUTIONS3D BIOTEK LLC.
EVOTEC SE AKRON BIOTECH
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The market is projected to grow from $2.5 billion in 2022 to $14.9 billion in 2028, at a compound annual growth rate (CAGR) of 26.5% during the forecast period.
  • Government regulations and mandates
  • Rising demand for tissue engineering
  • Advancements in healthcare technology.
The 3D cell culture market is segmented based on type, application, end-user, and region.
By type, the research segment is anticipated to dominate the market by the end of 2028.
North America holds the highest market share in the market in terms of region.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Consulting Editor’s Credentials

Dr. Marianna Tcherpakov has more than 10 years of experience as a bench scientist specializing in the areas of biochemistry, cell biology, assay development, antibody and drug manufacturing. She has authored several scientific publications in peer review journals. In the last 10 years, Marianna worked as a business development professional in CRO/CDMO industry. She is familiar with pharmaceutical and biotech landscape, trends and potential future developments in industry.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
. Title/Chapter NamePagesPrice Member Price
Full Report: 3D Cell Cultures: Technologies and Global Markets419 $5,500 Free
Chapter- 1: Introduction4Free DownloadFree
Chapter- 2: Summary and Highlights4$250Free
Chapter- 3: Market Overview32$420Free
Chapter- 4: Market, by Type129$1,693Free
Chapter- 5: Assays, Imaging and Analysis29$381Free
Chapter- 6: Regulation and Standardization12$158Free
Chapter- 7: 3D Models for Cancer32$420Free
Chapter- 8: Landscape for Toxicology and Drug Safety Testing64$840Free
Chapter- 9: Market Breakdown by Region13$171Free
Chapter- 10: Stem Cell Landscape24$315Free
Chapter- 11: Regenerative Medicine: Organ Transplants and Skin Substitutes11$144Free
Chapter- 12: Company Profiles65$853Free
Published - Aug-2020| Analyst - Cort Wrotnowski| Code - BIO140C

Report Highlights

The global market for cell culture should grow from $10.3 billion in 2020 to $14.8 billion by 2025, at a compound annual growth rate (CAGR) of 7.5% for the period of 2020-2025.

Report Includes

  • 79 tables
  • An overview of the global markets and technologies for 3D cell cultures
  • Estimation of the market size and analyses of global market trends with estimated data from 2020 to 2024, and projections of compound annual growth rates (CAGRs) through 2025
  • Information on analytical systems used in tissue and cell culture, cellomics and human cancer model initiative (HCMI)
  • Details about assay development for mesenchymal stem cells, In Vitro testing of adventitious agents and description of assays and assay kits
  • A look at the main classes of models for researching cancer and other diseases, benefits of 3D models to cancer research and description of 3D engineered scaffolds
  • Analysis of the market's dynamics, specifically growth drivers, restraints, and opportunities and discussion on the impact of COVID-19 on the world of cell culture
  • Insights into U.S. regulatory status of bioprinted products; basic guidance for the regulation of biologics, regenerative medicine and xenotransplants
  • Relevant patent analysis, including recent activity and a list of key patents
  • Market share analysis of the major players in the industry and their comprehensive company profiles including Agilent Technologies, BioVision Inc., Cell Applications Inc., Envisiontec Inc., Mitra Biotech Inc., Promega Corp. and Thermo Fisher Scientific
Published - May-2017| Analyst - Robert Hunter| Code - BIO140B

Report Highlights

The three-dimensional cell culture market reached $1.0 billion in 2016 and should reach $3.9 billion in 2021, with a compound annual growth rate (CAGR) of 30.7% from 2016 to 2021.

Report Includes

  • An overview of the global markets and technologies for 3D cell cultures.
  • Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
  • Information on 3D technologies, with a focus on representative platforms, including cube, spherical droplet, stacked plate, magnetic bead, and other platforms.
  • Value-chain analysis at the following levels: key innovation or founding intellectual property, prototyping, beta testing, and research collaborations or relationship building.
  • Analysis of the market's dynamics, specifically growth drivers, restraints, and opportunities.
  • Relevant patent analysis, including recent activity and a list of key patents.
  • Profiles of major players in the industry.
Published - Jan-2015| Analyst - Robert Hunter| Code - BIO140A

Report Highlights

The three dimensional cell culture market was $438.1 million in 2013. This market is expected to grow to $586.1 million in 2014 and about $2.2 billion in 2019, with a compound annual growth rate (CAGR) of 30.1%.

Report Includes

  • An overview of the global markets and technologies for 3D cell cultures.
  • Analyses of global market trends, with data from 2013, estimates for 2014, and projections of compound annual growth rates (CAGRs) through 2019.
  • Information on 3D technologies with a focus on representative platforms including cube, spherical droplet, stacked plate, magnetic bead, and other platforms.
  • Value chain analysis at the following levels: key innovation or founding intellectual property, prototyping, beta testing, and research collaborations or reltationship building.
  • Analysis of the market's dynamics, specifically growth drivers, restraints, and opportunities.
  • Relevant patent analysis including recent activity and a list of key patents.
  • Comprehensive profiles of major players in the industry.

Related Reports

Laboratory Animal Models, 3D Cultures and Organoids: Global Markets

Published - Sep 2022 | Publisher - BCC Publishing | Code - PHM204B

The global market for organoids is estimated to increase from $1.4 billion in 2022 to reach $3.7 billion by 2027 with a compound annual growth rate (CAGR) of 22.2% from 2022 through 2027.

Current Bioprinting Prospects and Future Innovations

Published - May 2019 | Publisher - Kamna Jhamb | Code - BIO176A

The global bioprinting market should reach $1.4 billion by 2024 from $306.2 million in 2019 at a compound annual growth rate (CAGR) of 35.4% for the period 2019 to 2024.

Recent Reports

Life Science Tools and Reagents: Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - BIO083E

The global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023. This market is expected to grow from $53.2 billion in 2024 to reach $66.5 billion by the end of 2029, at a CAGR of 4.6% during the forecast period of 2024-2029.

RNAi Technologies and Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - BIO127C

The global market for RNAi technology is estimated to increase from $2.1 billion in 2023 to reach $4.8 billion by 2029, at a compound annual growth rate (CAGR) of 14.8% from 2024 through 2029.

Metabolomics: Technologies and Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - BIO055E

The global market for metabolomics technologies is expected to grow from $16.4 billion in 2024 and is projected to reach $30.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% during the forecast period of 2024 to 2029.

Global Recombinant Proteins Market

Published - Jul 2024 | Publisher - BCC Publishing | Code - BIO254A

The global market for recombinant proteins is estimated to increase from $132.4 billion in 2023 to reach $203.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.5% from 2024 through 2029.

Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics

Published - Jun 2024 | Publisher - Gundreddy Gopinadh | Code - BIO157C

The global market for polymerase chain reaction for point-of-care diagnostics is expected to grow from $1.6 billion in 2024 to $2.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.9% from 2024 through 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
3D Cell Cultures: Technologies and Global Markets
Sample Report